Skip to content

Putting Money in MedTech

Register for 2024’s leading MedTech startup & investor summit

MedTech World

2024

We are a global event management company that hosts an annual investor and entrepreneur conference in the medtech and health tech space in Malta, Europe, alongside multiple premier roadshow events worldwide. At MedTech World, we trust in fostering collaboration among all stakeholders to attain improved healthcare for everyone. At the heart of our mission is a strong belief that each innovative startup deserves funding, and by fostering entrepreneurship, we are contributing to a robust and sustainable healthcare environment. Join over 3,000 attendees from diverse regions including the UK, Europe, North America, Asia, the Middle East, and North Africa. Engage in unparalleled networking meetups, explore investment opportunities with top MedTech investors, and connect with startups at the forefront of transforming the medtech sector.

MedTech World Malta

3,000+

attendees

350+

speakers

200+

partners

150+

startups

100+

investors

Top Speakers

2023 event

Carolina Aguilar

CEO & Co-Founder, INBRAIN Neuroelectronics

Carolina Aguilar possesses over 15 years of expertise in healthcare, particularly in Medical Devices such as Neuromodulation and Diabetes, as well as experience in consumer goods. She has a passion for cross-pollinating ideas between the scientific and Fast-Moving Consumer Goods (FMCG) worlds. Recognizing the brain as one of the most important organs, Carolina has dedicated a significant portion of her time to its study. This led her to join Medtronic, the world’s largest Medtech company, where she led the most advanced neural interface program at that time in Deep Brain Stimulation (DBS). During her tenure in DBS, which spanned a decade, Carolina managed complex businesses in this field, overseeing a Profit and Loss (P&L) of over $140 million. She led large local and global teams, achieving high single to double-digit growth percentages year-over-year. In recent years, she has also been involved in Value-Based Healthcare (VBHC), driving the expansion of the first VBHC provider model in Diabetes for Medtronic. This endeavor included signing a major deal in Saudi Arabia and winning the European VBHC prize in 2017. Carolina’s experience with VBHC reinforced her belief in delivering solutions focused on patient outcomes, leading to patient empowerment and the sustainability of healthcare. After an extensive corporate career, Carolina made the decision to contribute to critical innovation at a faster pace. She recently co-founded INBRAIN Neuroelectronics, a company operating in the field of Bioelectronics. Carolina assembled an incredible team with backgrounds in nanoscience, Medtronic, and Philips. Adhering to VBHC principles, INBRAIN Neuroelectronics is developing the next generation of neural interfaces using graphene, the material that earned the Nobel Prize for Geim and Novoselov from Manchester University in 2010. The company is a spin-off from the Graphene Flagship’s partner, the Nanoscience & Nanotechnology Institute of Catalonia (ICN2). Leveraging the unique properties of graphene, they aim to decode brain and nerve signals to create breakthrough and sustainable medical solutions.

Oliver Bisazza

CEO at MedTech Europe

Oliver joined MedTech Europe in 2017, originally heading the department which supports members in implementing new and changing EU regulatory requirements affecting the medical technology industry. In January 2023, Oliver assumed the role of Chief Executive Officer, responsible for the association’s overall management and strategy and reporting to the Board of Directors. Oliver’s passion is to see the value of medical technology innovation fully recognised as a source of solutions to the many challenges facing healthcare systems, economies and societies, both in Europe and around the world. Prior to joining MedTech Europe, he worked at Medtronic as Director of Regulatory Policy for EMEA. In addition to this company experience, Oliver had various trade association roles in Brussels, at COCIR (the European association for the radiological, electromedical and healthcare IT industries) and at EDANA (the industry association for the nonwovens and related industries). Oliver is a native speaker of English, and a dual national of Australia and Malta. When not working, he enjoys travel, spending time with his family, and rock-climbing.

Darshana Zaveri

Managing Partner, Catalyst Health Ventures

Darshana is Co-Founder and Managing Partner of Catalyst Health Ventures. She is actively involved in all aspects of fund management and has led CHV’s investments in the medical device and diagnostics markets. Darshana currently serves as an advisor of the Deshpande Center for Technological Innovation at MIT, as a Board Director of the New England Venture Capital Association and as a lead advisor to the Portfolia FemTech Fund.

Ina Laura Perkins

CEO, Scandinavian Real Heart

I am a biomedical scientist and entrepreneur with commercialisation experience in the start-up phase in the field of regenerative medicine and medical devices. My background is a mix of applied research focused on product development and business development of biomedical innovations. I have worked with biotechnology and pharmaceuticals, stem cells, and medical devices. My expertise ranges from developing products from the idea stage to proof of concept and the non-clinical development stage. Having worked in various start-ups for 15 years, I am used to wearing many hats and have developed a broad range of commercials skills including commercial technology appraisal, intellectual property portfolio management (freedom to operate analysis, patent filing), securing funding (academic and government grants, venture capital), and expanding and promoting research (academic publications, conference presentations). Currently I manage the development of a novel total artificial heart, the Realheart TAH, focusing on minimising the impact caused by shear stress and foreign materials on the blood cells and proteins.

Joseph W. Rafferty

CEO & Founder at VESTECK Inc.

VESTECK is a clinical stage endovascular platform technology in the aortic repair, structural heart and surgical markets.  The “Suture-Tight”tm catheter delivers preloaded nitinol sutures to EVAR/TEVAR endovascular grafts securing the grafts to the aorta, either at the time of initial implant or reintervention.  Global opinion leaders tell us that the “Suture-Tight”tm will bring significant benefit to patients, physicians and payors. Mr. Rafferty has leveraged his education with global strategic organizations like ACS/Guidant, CR Bard and J&J Ethicon, to create value, bringing novel technology to the global health care community at startup companies like Pathway Medical, NMS and VESTECK. Mr. Rafferty is a proud graduate of The Temple University, Philadelphia, PA. He and his wife Beth are the proud parents of 4 wonderful children and 4 beautiful grandchildren.

Bhavesh Barot

Operating Partner & CBO at Truffle Capital

Cathy Skinner

CEO at NXgenPort Inc

CATHY SKINNER, CEO is an Executive Healthcare leader with 20+ years of successful experience building businesses, differentiated products, and services that manage healthcare costs and improve patient outcomes.

Julie Adrian

Founder and CEO at Alverium Health

Julie is a C-level industry expert with 25+ years dedicated to corporate growth leadership with experiences ranging from early clinical development through commercialization across pharmaceutical, biotech, and device sectors. Her achievements are based on delivering consistent, above market growth for global and regional initiatives, corporate marketing, and complete life cycle brand management.

Joana Cartocci

Co-founder and COO, Robeauté

With 10+ years in operational roles in deep-tech projects, Joana Cartocci has a multidisciplinary and multicultural background. Her career spans from linguistics and international relations to coordination roles in deeptech projects that bridge tech, citizen movement, art, well-being and politics. In 2017, she co-founded Robeauté with Bertrand Duplat, to create the next generation smart neurosurgical delivery device to better understand and treat brain pathologies.

Kwame Ulmer

Venture Partner at Wavemaker Three-Sixty Health

Kwame Ulmer is a venture partner at Wavemaker Three-Sixty Health. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams)

Andrew Glass

CEO, Vivasure Medical

Andrew Glass is the CEO of Vivasure Medical, an innovative medical device start-up based in Ireland. Previous to Vivasure, Andrew was a senior executive at Abbott Laboratories for over fifteen years.  He has significant multi-cultural leadership experience in Asia, Europe, and the United States.  Andrew holds a BSE in Chemical Engineering from Princeton University and an MBA from the Harvard Business School.

Sanchita Pasi

Senior Investment Manager at Sagana

Sanchita Pasi is a Senior Investment Manager at Sagana with a Pharm.D and an MBA from SDA Bocconi. Sanchita’s experience spans across international MedTech product management and commercialization from her time at Abbott Laboratories. She then transitioned to venture capital starting at Nina Capital and now impact investing at Sagana. She is excited to meet founders who are need-driven and fueled by the goal to improve access and affordability for healthcare worldwide. She has indian roots, a mediterranean upbringing, and is also a painter by night.

Wesley Jones

CEO & Co-Founder at Vonova

Wesley Jones, MBA MS, is a Biodesign fellow and medical device engineer specialized in the development of minimally invasive, catheter-based, technology. Mr. Jones has spent a decade leading technical teams from concept to commercialization and has successfully launched 11 devices to market at Medtronic and Acutus Medical.

Laura Indolfi

CEO and Co-Founder at PanTher Therapeutics

Laura Indolfi is the Co-Founder & CEO of PanTher Therapeutics, an early stage spin-out from MIT and MGH that provides superior technologies for revolutionizing the treatment of locally advanced solid tumors. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledge to drive the company’s vision.
Prior to PanTher, she was a research associate at the Harvard-MIT Institute for Medical Engineering and Science, and served as an entrepreneur-in-residence at the MGH Cancer Center. She strongly believes in the power of outreaching initiatives to promote research awareness and foster the public audiences discovery of the beauty of science. In 2014 the line of clothes Cytocouture, created in collaboration with Colombian designer Carlos Villamil and inspired by her cell-therapy research, won the global competition Descience.

Nir Goldenberg

Technology Development Manager, Mayo Clinic Ventures

Nir joined Business Development’s Mayo Clinic Ventures division in 2022 as a technology development manager. He is responsible for facilitating the development and commercialization of technologies from Mayo Clinic’s Department of Surgery by working with internal stakeholders, external companies, entrepreneurs and investors.
Prior to joining Mayo, Nir was CEO of Trendlines Innovation Labs (TIL), which focuses on in-house and collaborative invention and investment opportunities in the life science space. Prior to his appointment as CEO, he served as TIL’s VP Business Development. Before Trendlines, he was director of commercial development in Europe at INSIGHTEC Ltd., a global MR-guided focused ultrasound surgery company.
Nir holds a BSc in engineering from La Sapienza University of Rome.

Brittany Barreto, PhD

Chief Innovation Officer, FemHealth Insights

Dr. Barreto is a global key opinion leader in women’s health innovation and widely known as the Voice of FemTech. She is a Molecular Geneticist by training with experience founding and investing in startups. She is founder of FemHealth Insights and host of the FemTech Focus podcast.

Michael Wallace

Co-Founder & Venture Partner, Early Bird Medical & ShangBay Capital

Michael is a medical device executive, serial entrepreneur, inventor, and part-time venture capitalist. He has a passion for commercializing disruptive technologies that help patients.He has co-founded 5 companies with 4 successful exits to date. Most recently, in 2021, Michael sold Devoro Medical to Boston Scientific.

Lloyd Diamond

CEO, Pixium Vision

Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.

Juliana Elstad

CEO at Vibrato Medical

Juliana is a CEO, board member, entrepreneur, and advisor with over 20 years of experience bringing medtech innovation to patients in startup to multi-billion-dollar companies. Over the course of her career Juliana has created companies, facilitated exits doubling shareholder expectations, and developed strategies to grow a billion-dollar business at 15+%.

Anita Watkins

Managing Director at Rex Health Ventures

Anita manages Rex Health Ventures (RHV), the corporate venture fund of UNC Health, the largest academic health system serving the state of North Carolina. RHV’s mission is to spur innovation in healthcare through equity investment and partnership with emerging health companies. She currently serves on the boards of Bio54, Biostable Science and Engineering, ReDiscovery Life Sciences, Vergent Bioscience, and Censinet.

Josep LI. Sanfeliu

Managing Partner & Co-founder, Asabys Partners

Josep has more than 15 years of experience as VC, first co-founding Ysios Capital in 2008 and more recently founding Asabys Partners in 2018 which is managing close to € 300 Mio in health innovation investments. He has specialized in life sciences and healthtech investments in Europe, Israel and the US with more than 10 investments and Boards in the space and some successful exits. Previously he has had a hybrid career in law and finance in the pharma and healthcare world working for Cuatrecasas, KPMG, DomusVi and Almirall. Josep has a Law Degree from Universitat Pompeu Fabra, a Master of Laws from University of Michigan and an MBA from IESE Business School.

Rachel Offenburg

Founder at Ravn Partners LLC

Rachel Offenburg is a passionate advocate for the growth and success of biotech and life science startups. Her entrepreneurial spirit and commitment to this dynamic sector shine through in her role as a consultant, where she has carved out a niche in providing invaluable business strategy support to early-stage ventures.Rachel assists startups in charting their course to commercialization with her expertise in fundraising and investor strategy, a critical aspect of any budding startup venture’s journey. Rachel’s proficiency in business development helps startups forge essential partnerships and collaborations that can drive innovation and growth.Rachel has a master of business administration (MBA) from the University of Virginia Darden School of Business, with a focus on entrepreneurship, and a BS in biology and business from Emmanuel College.

Aashiish Agnihotri, PhD

Founder & CEO, xDot Medical Inc

Malek Nasr

Co-Founder & Vice President, HighLife

Co-founder of HighLife, a Cardiovascular Medtech company based in Paris and California, Malek has a biomechanical engineering background. He has developed a Transcatheter Mitral Valve Replacement technology from early concept to production. After conducting pre-clinical testing then First In Human implant, he is now leading Therapy Development and clinical implementation globally.

Our Partners

We proudly collaborate with over 200 partners in the MedTech space, including top medical device venture capitalists, industry leaders, and tech innovators. Join us in driving healthcare innovation and investment in the global MedTech landscape.
5
Key Partners
150+
Supporters
100+
Investors
50+
Media Partners

Interested in sponsoring MedTech World’s next event?

Let’s Connect

Startup Pitch

A unique opportunity for entrepreneurs to gain exposure, receive feedback, and secure funding for their ventures
What’s included?

booth

presentation

consultancy

networking

PR

leads

apply now

Moments from our events

Testimonials

What others have to say after experiencing MedTech Malta 2023

Kwame Ulmer

Venture Partner, Wavemaker Three-Sixty Health

Med-Tech World is special. It is the only event that has featured a head of state, investors from around the world focused on medtech and serious entrepreneurs. The conveners have produced a delightful and immersive experience in a setting that invites expansive conversations. I believe this formula will drive the success of medtech companies and move their solutions towards expanded patient access.

Martin Gomez

Partner & Co-Head MedTech Practice, Group Goodwin Procter

MedTech Malta was the best conference I have been to in a long time. Not only did it offer plentiful networking opportunities with high caliber Medtech companies and investors, but the panel discussions were both relevant and engaging. The event did not disappoint and I look forward to returning again next year.

Julie Adrian

Founder & CEO, Alverium Health

“Med-Tech World 2023 was one of the best tradeshow experiences I’ve ever had. It provided an excellent platform to share the Alverium Health story, as it was intimate enough to meet almost everyone there and interact with them in a meaningful way. With a solid mix of both innovators and investors in attendance, everybody was very accessible and we were able to make some outstanding connections that have already provided value to both our clients and the growth of our business. We are already looking forward to what MTW 2024 has to offer!

Linus Rieder

Principal, 415 Capital Management GmbH

A very intimate conference that provides a great mix of startups and investors, not to forget to mention that it takes place on a stunning Island!

Amir Soltanianzadeh

Founder & Managing Partner, Solardis Health Ventures

MedTech Malta brings together the leading MedTech entrepreneurs, investors, and strategics at one of the most unique venues in the world. This is a must-attend event for you everyone in MedTech, and I will be there every year.

lloyd Diamond

CEO, Pixium Vision

The Medtech Malta conference was a well-organized event that provided an excellent forum to interact with many of the thought leaders in the global medtech industry. As the CEO of a disruptive medtech company, it can be quite lonely at times. It was great to spend time with other CEOs in similar situations and get re-energized

Pierre Attard

Managing Director, PTL Limited

Our presence at the Med-Tech World Conference aided us in increasing our exposure in the digital health industry. Being awarded ‘Best Contributor to Local Healthcare Industry’ at the Med-Tech World Awards Gala topped it off. We eagerly look forward to their continued contributions at future Med-Tech World events.”

Maria Bugeja

CEO, JamesCo

The Med-Tech World Summit was an incredible experience for us at Jamesco. This event beautifully brings together the medical industry’s key stakeholders showcasing their innovation trends, technologies, and products and the potential stakeholders interested in such products. Jamesco took this opportunity to host a doctors’ educational lunch during the event and proudly introduced two new exciting products for Malta and Europe. The participating audience could not have been better selected for our purpose.

Oliver Bisazza

CEO, MedTech Europe

Innovation in the medical technology industry is the lifeblood of progress in healthcare. It drives the development of cutting-edge medical devices and technologies that save lives, enhance patient care, and improve healthcare delivery. Embracing and nurturing innovation is not just a choice; it’s an imperative for ensurin a brighter and healthier future for all.

Dr. Sanjay Shrivastava

CEO, Innova Vascular, Inc.

Med-Tech World is the best investor conference that I have ever attended. It offered a friendly environment for startup companies to mingle with potential investors. The investors were consistently present at the event and were generally approachable. I enjoyed the interactions with fellow CEOs. I also found the panel discussions to be informative. Lastly, it was nice to have the prime minister of Malta attend the event to deliver a keynote speech. I’d go back to this event again.

Expand Your Network with MedTech Match

MedTech Match is designed to facilitate meaningful connections and set up one-on-one meetings among attendees before, during, and after our events. It’s your gateway to engage with industry leaders, innovators, and investors, enhancing your networking experience in the MedTech community.